Central serotonin (5-hydroxytryptamine, 5-HT) function has a role in a range of genetically influenced psychiatric diagnoses and behaviors. Several human 5-HT receptor polymorphisms are 'candidate alleles', altering in vitro function, and potentially affecting behavior and drug response. The 5-HT 2A His452Tyr polymorphism alters signal transduction, and has been associated with diminished efficacy of clozapine in schizophrenia. Another 5-HT 2A receptor polymorphism consists of the silent thymidine-cytosine substitution (102T4C), which has been controversially associated with schizophrenia. We investigated the role of His452Tyr and the 102T4C in behavior and in vivo intermediate biochemical phenotypes. Intracellular 5-HTinduced Ca 2 þ release by platelets and fenfluramine-induced prolactin release by pituitary were evaluated in 27 psychiatrically interviewed subjects (including both impulsive patients and controls) stratified by His452Tyr genotype and also genotyped for a second 5-HT 2A polymorphism, 102T4C. Subjects with increased measures of impulsivity showed decreased postreceptor 5-HT function, as indicated by reduced 5-HT-induced Ca 2 þ release, but no alteration in net 5-HT function, as measured by fenfluramine response. No significant effects of either polymorphism were associated with altered 5-HT-induced calcium response or fenfluramine-stimulated prolactin release. One available Tyr452/Tyr452 homozygote had diminished Ca 2 þ release and one of the highest levels of fenfluramine response. Although not statistically significant, the effect of the T102C, but not the His452Tyr, genotype on prolactin level change over time was associated with a medium to large strength of association (treatment magnitude of T 2 ¼ 0.10), suggesting that further study is warranted. Keywords: serotonin; platelet; calcium; T102C; His452Tyr; impulsivity; fenfluramine Brain serotonin (5-hydroxytryptamine, 5-HT) function has been reported to have a role in a wide range of behaviors and behavioral diseases including several that involve impulse control: binge eating, earlyonset alcoholism, major depressive disorders, suicide attempts, and impulsive aggression in patients with a wide range of psychiatric diagnoses.
Brain serotonin (5-hydroxytryptamine, 5-HT) function has been reported to have a role in a wide range of behaviors and behavioral diseases including several that involve impulse control: binge eating, earlyonset alcoholism, major depressive disorders, suicide attempts, and impulsive aggression in patients with a wide range of psychiatric diagnoses. 1 This heterogeneous array of disorders linked with reduced central 5-HT functioning may be inter-related by the general trait of irritable impulsivity.
2,1 The mechanisms by which decreased 5-HT activity is tied to impulsivity are, however, unknown as is the role of variation of genes influencing serotonin function.
For the analysis of genetically influenced complex behaviors and pharmacological responses, intermediate (mediating) neurobehavioral or biochemical phenotypes are invaluable to strengthen findings and validate them mechanistically. 5-HT has a role in a variety of genetically influenced complex disorders and behavioral problems. These include several behaviors that are at one end of the spectrum of impulsivity, namely, binge eating, early-onset alcoholism, depression, suicide attempts, and unprovoked interpersonal violence. Several of these diseases or behaviors-that is, alcoholism, depression, binge eating, and suicide-are genetically influenced, and the roles of two polymorphisms in alcoholism vulnerability have even been confirmed, namely, ADH2 Glu47Lys and ALDH2 Glu487Lys. 3 As behavioral traits are complex and multifactorial, linkages of several serotonin gene polymorphisms, for example, the 5-HT 1B serotonin receptor and antisocial alcoholism, 4 tryptophan hydroxylase and suicidality, 5 and the serotonin transporter and anxiety/dysphoria 6, 7 require verification and fuller explanation at the level of the physiology connecting gene variant to complex behavior. Serotonin receptors and the serotonin transporter are also important pharmacological targets in the treatment of psychiatric disorders. The 5-HT 2A receptor is important in the mechanism of action of atypical antipsychotic medication, while the serotonin transporter is the site of action for the selective serotonin reuptake inhibitors (SSRI).
Several naturally occurring variants of serotonin receptors have been identified that may help explain the heritability of behaviors associated with 5-HT and shed light on the link between central 5-HT function, psychopathology, and drug response. One polymorphism in the gene encoding the 5-HT 2A receptor consists of a thymidine-cytosine substitution: 102T4C. Although this substitution is silent (ie it does not result in an alteration of the amino-acid sequence of the 5-HT 2A protein), it has been controversially associated with schizophrenia. [8] [9] [10] A second 5-HT 2A variant is a histidine-tyrosine (HisTyr) missense substitution at amino acid 452 in the Cterminal region of the receptor. Pharmacological investigation has shown that this variant is functional. Although there is no significant difference in radioligand binding to platelet 5-HT 2A receptors, the rarer (allele frequency 0.09) Tyr452 allele shows diminished signal transduction. 11 The first studies have been reported on the relationship of functional genetic variation at these receptors to pharmacogenetic differences in drug response. Collier et al 12 have summarized results supporting a relationship of HTR 2A His452Tyr to clozapine response in schizophrenics. In this meta-analysis, 10 Tyr452/Tyr452 homozygotes were available; only two were clozapine responders.
The neurobiology of serotonin directly predicts several intermediate (mediating) phenotypes that could be evaluated to better resolve the action of genotypes. Intermediate phenotypes for serotoninrelated behaviors include levels of serotonin and its metabolites in CSF and brain, physiological measures such as body temperature, behavioral measures of anxiety and impulsivity, endocrine measures including measures of drug response such as fenfluramine 13 and m-CPP response, and direct measures of protein concentrations in living or post-mortem brain. For example, HTTLPR, a serotonin transporter promoter polymorphism influencing in vitro gene transcription, and reportedly involved in anxiety, was directly correlated with in vivo serotonin transporter density in vivo 14 and in post-mortem brain. 15 Quantification of neurochemical consequences of pharmacological challenge can evoke a response reflecting 'net' or overall 5-HT activity. Probes for central 5-HT systems include 5-HT precursors, 5-HTreleasing agents, selective 5-HT uptake inhibitors, and direct 5-HT agonists and antagonists. Fenfluramine acts somewhat differently than the more recently developed SSRIs in that it increases extracellular 5-HT concentrations by both blocking 5-HT uptake and reversing the usual outside-to-inside directionality of the 5-HT transporter in the presynaptic membrane, simultaneously releasing 5-HT and blocking its uptake. [16] [17] [18] The resulting increases in extracellular 5-HT levels stimulate postsynaptic 5-HT 2A receptors in the anterior pituitary and, via an inositol 1,4,5-trisphosphate (IP 3 )/diacylglycerol-linked second messenger system, stimulate prolactin secretion, which can be measured in peripheral blood samples. Thus, measurements of fenfluramine-induced prolactin release integrate both pre-and postsynaptic elements and reflect net 5-HT functioning. Although prolactin response is mediated by a number of neurotransmitter systems, the 5-HT 2A receptor is believed to play a prominent role in fenfluramine-induced prolactin release.
Patients with violent suicidal and/or impulsive aggressive behaviors have consistently been shown to exhibit decreased fenfluramine-induced prolactin release. 13 Convicted murderers with a diagnosis of antisocial personality disorder, 19 impulsive/aggressive patients with post-traumatic stress disorder, 20 and men rated as highly aggressive 21 exhibit impaired fenfluramine-induced prolactin release. Although the association between decreased central 5-HT function and impulsive aggression is usually observed in patients diagnosed with a personality disorder, a recent report indicates that heightened aggression and impulsivity in a sample of normal men were significantly correlated with low fenfluramine-induced prolactin response. 22 A second useful strategy to assess components of central 5-HT function is to examine these components in more easily accessible peripheral locations. Circulating blood platelets contain a functional 5-HT signaling system that is largely identical to that in the central nervous system. The sequence of the 5-HT transporter is identical in human brain and platelets. 23 Similarly, the 5-HT 2A receptors of human platelets and frontal cortex have the same nucleotide sequence 24 as well as ligand binding profiles and affinities. 25 Agonist binding to these 5-HT receptors on the platelet surface activates the IP 3 second messenger system, leading to mobilization of cytosolic Ca 2 þ . 26 In contrast to the assessment of 'net' 5-HT function provided by measurements of fenfluramineinduced prolactin release, determination of agonistinduced Ca 2 þ release from platelets allows the assessment of the function of postreceptor of 5-HT signaling components.
A number of studies have shown that the treated impulsivity as well as impulse-control-related disorders are correlated with measures of decreased functioning in platelet 5-HT systems. 5-HT stimulation Ca 2 þ release has been shown to be increasingly related to treatment of impulsivity. 27 Decreased radioligand binding to platelet 5-HT uptake sites has been observed in patients with mental disorders characterized by hyperactive and/or aggressive behavior 28 and in individuals with personality disorders and high Life History of Aggression and Buss-Durkee hostility inventory (BDHI) assault scores. 29 Increased numbers of 5-HT 2A receptors have been correlated with assaultiveness in patients with personality disorders, 30 and with the degree of medical damage resulting from suicidal acts. 25 McBride et al 25 also found that the ratio of 5-HT-amplified platelet aggregation (a response mediated by 5-HT 2A receptors) to 5-HT 2A receptor number, an index of the responsivity of platelet 5-HT receptors, was lower in suicide attempters vs nonattempters or normal controls. This suggests that alterations in the 5-HT 2A -linked second messenger signaling may have a role in impulsivity.
In the present study, we examined impulsivity scores, postreceptor 5-HT function (via 5-HT-induced Ca 2 þ release from platelets), net 5-HT function (via fenfluramine-induced prolactin release), and the genotype of two 5-HT 2A receptor loci in a sample of impulsive subjects and healthy volunteers. HTR 2A 102T4C is an abundant polymorphism (rare allele frequency 0.40), which is in near allelic identity with a promoter polymorphism À1438, and both have been associated with clozapine response in schizophrenics 31 and psychopathology in the anxiety/dysphoria domain. However, neither of these HTR 2A polymorphisms is known to be functional. 32 HTR 2A His452Tyr is a less common polymorphism (rare allele 0.09). This polymorphism, however, does appear to alter signal transduction, 11 and the more poorly transducing 452Tyr allele has been associated with diminished response to clozapine in schizophrenics. 31 We also further investigated the possibility of relationships between impulsivity, 5-HT genotype, and both peripheral and central measures of 5-HT function.
Methods

Subjects
The study was approved by the Human Subjects Committee of the Long Beach Veterans Affairs Healthcare System and was conducted prior to the removal of fenfluramine from the market. All subjects provided informed consent to participate. Subjects had participated in an earlier study in which His452Tyr genotype had been determined. Efforts were made to recruit subjects from this group who were His452/Tyr452 heterozygous and an agematched group who were His452/His452 homozygous. This resulted in the selection of 27 male subjects. In all, 14 subjects (age 40710.7 years) were graduates of a residential alcohol unit where they had been sober for at least 8 weeks at the time of testing. The remaining subjects were 13 nonpatient volunteers (age 41.4711.6 years) who did not have a history of psychiatric disorder or other current illness. Owing to genotype selection, the frequency of the Tyr452 allele in this data set was 0.23, as compared to 0.09, in a Caucasian population sample.
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102T4C and His452Tyr are not in significant linkage disequilibrium and subject selection was based on His452Tyr, so it is not surprising that the frequency of 102C was 0.52, and not significantly different from that previously observed in Caucasians. Baseline assessment included a psychiatric and medical history, the Barratt Impulsivity Scale (BIS-10), the Brown-Goodwin Aggression Questionnaire (BGA), and the Structured Clinical Interview for DSM-III-R (SCID II) Personality Disorder Questionnaire. The SCID II Questionnaire was followed up with the SCID II structured interview to establish the presence or absence of a personality disorder. The 14 subjects recruited from the residential program were diagnosed with alcohol dependence, but were free of other Axis I disorders and medical illness, and were not receiving psychotropic medication. Of these subjects, 10 also met criteria for an Axis II disorder.
Procedures
On the test day, subjects were n.p.o. after midnight. At 0800 a catheter was inserted in a forearm vein. As parameters of 5-HT function in platelets have been reported to vary according to the time of day, 33 all platelet blood samples were collected at 0830. These samples were collected via the catheter into tubes containing acid-citrate-dextrose (ACD) anticoagulant. At 1000, subjects received D-fenfluramine (30 mg, p.o.). Blood samples were collected every 30 min beginning at 0930 and ending at 1500. Subjects were permitted to drink fluids during the test period and remained in the research suite, engaged in quiet activities.
Neurochemical assays
Platelet preparation: 5-HT-induced calcium response was measured according to the method of Mikuni et al 34 with slight modification. Platelet-rich plasma (PRP) was prepared by centrifugation at 750 Â g for 3 min at room temperature (19-231C). Platelet concentration was adjusted to 2 Â 10 8 /ml using KrebsRinger-HEPES buffer. Final volume also was adjusted to contain 20% ACD. A PRP aliquot was then incubated with 3.0 mM fura 2-AM (5-oxazolecarboxylic acid, 2-(6-(bis(2-((acetyloxy)methoxy)-2-oxoethyl)amino)-5-(2-(2-(bis(2-((acetyloxy)methoxy)-2-oxoethyl)amino)-5-methylphenoxy)ethoxy)-2-benzofuranyl)-, (acetyloxy)methyl ester; Molecular Probes; Eugene, OR, USA) for 20 min at 371C. After centrifugation (1750 rpm, 7.0 min, room temperature), the platelet pellet was suspended in KRH (1.5 ml final volume). To facilitate resuspension of pellet, a volume ( 1 4 of final resuspension volume) of calcium-free KRH was added first, followed by normal KRH to final volume. Ca 2 þ release assay: PRP samples were added to a prewarmed (371C), stirred quartz cuvette, and placed in a Perkin-Elmer LS50B spectrofluorometer with excitation at 340 and 380 nm and emission detection at 510 nm. 5-HT was added to produce a final concentration of 10 mM. The R max , defined as the fluorescence ratio when the concentration of free fura 2-AM is zero (ie at saturating Ca 2 þ levels), was determined by adding Triton which solubilizes the membrane making it permeable to calcium. Subsequently, R min defined as the fluorescence ratio when Fenfluramine-induced prolactin release: Plasma levels of fenfluramine and its principal metabolite, norfenfluramine, were measured using gas chromatography with electrochemical detection. 36 The lower limits of detection were 2 ng/ml for fenfluramine and 3 ng/ml for norfenfluramine. Plasma prolactin levels were determined using a commercially available radio immunoassay kit (Diagnostic System Lab (DSL-10-4500)). The primary antibodies used were specific for prolactin as shown by preabsorption and crossreactivity assays by the manufacturer. The lower limit for detection was 2 ng/ml (CV 8.7%).
5-HT genotypes:
The polymorphisms were genotyped from genomic DNA prepared from peripheral blood as described previously. 37 Briefly, the 102T4C and His452Tyr polymorphisms were genotyped after PCR amplification and using restriction enzyme assays . 38 The primer pairs for DNA amplification were: 102T4C, responses and measures of impulsivity were determined using stepwise regression.
Prolactin response and 5-HT genotype: Two separate mixed analyses of variance were conducted on the data. In each analysis genotype was used as a between-subjects factor, while timed measurements of circulating prolactin levels were a within-subjects repeated measure. In the first analysis of variance (ANOVA), 102T4C was used as the predictor variable, while prolactin response was the dependent variable. The second ANOVA was carried out using the His452Tyr amino-acid substitution as the predictor variable and again prolactin secretion was the dependent variable. Subjects were classified as homozygous or heterozygous His452/Tyr452. As only one subject was found to be homozygous Tyr452/ Tyr452, he was included in the heterozygous group. For all statistical analyses, significance was defined at an alpha level of 0.05.
Results
Serotonergic function and impulsivity
Regression analysis showed that there was no significant correlation between fenfluramine-induced prolactin release and impulsivity (as measured by BIS (P ¼ 0.323) scores) or 5-HT-induced Ca 2 þ release (P ¼ 0.266). There was, however, a significant inverse correlation between platelet 5-HT-induced Ca 2 þ release and BIS scores (r ¼ À0.503, P ¼ 0.008) (Figure 1 ).
5-HT 2A receptor genes
Genotype frequencies for subjects at the two 5-HT 2A receptor gene loci are shown in Tables 1 and 2 . In addition, the mean platelet calcium response, fenfluramine (including norfenfluramine) levels and total scores for the BIS are reported for each group.
T102C
The prolactin response to fenfluramine for each of the 102T4C genotypes is shown in Figure 2 . As a violation in the assumption of sphericity was observed, the degrees of freedoms were adjusted by multiplying them with the Greenhouse-Geisser Epsilon (0. 
His452Tyr
The prolactin response to fenfluramine for each of the Tyr452 and His452 alleles is shown in Figure 3 . Again, because a violation in the assumption of sphericity was observed, the degrees of freedoms were adjusted by multiplying them by the Greenhouse-Geisser Epsilon (0.19). ANOVA for fenfluramine-induced prolactin release showed a significant main effect of time on the prolactin response (F(2.13, 
Discussion
In an effort to further investigate the inverse correlation between impulsivity (as measured by BIS scores) and 5-HT-induced Ca 2 þ release from isolated blood platelets, the relationship of a functional 5-HT 2A polymorphism (His452Tyr) to this measure and to net serotonin function measured by fenfluramineinduced prolactin secretion has been studied. These results could also shed light on the pharmacogenetics of clozapine response, where the Tyr452 allele has been associated with diminished therapeutic efficacy. However, like the pharmacogenetic studies where significance emerged after the pooling of the rare homozygotes across a number of studies, our intermediate phenotype findings are also limited by the rarity of the Tyr452/Tyr452 genotype, which is found in about 8/1000 individuals and in only one subject available to us. While both measures of serotonin function were relatively extreme in the Tyr452/Tyr452 homozygote, and intermediate in HTR 2A His452/ Tyr452 heterozygotes, these differences were not statistically significant, indicating a need to evaluate serotonin function in additional Tyr452/Tyr452 homozygotes. Neither the T102C nor the His452Tyr polymorphisms of the 5-HT 2A receptor gene were associated with variations in measures of impulsivity, postreceptor 5-HT function, or net 5-HT function.
Although a significant genotype (T102C) by prolactin level change over time interaction was not observed, a treatment magnitude of T 2 ¼ 0.10 was observed, a medium to large strength of association. 9 Therefore, in order to observe a significant interaction with the same mean difference between genotypes over time as was obtained in this study with a power of 0.80, a sample size of 42 was estimated (PearsonHartley charts). In contrast, the omega squared for genotype (His 452Tyr) by prolactin change over time was 0.03, a relatively small treatment magnitude. 39 This suggests that further investigation may not contribute further insights for the His452Tyr genotype.
The lack of correlation between His452Tyr genotype and 5-HT-stimulated Ca 2 þ release would at first appear to be in conflict with Ozaki et al, 11 who found significant blunting of the shape of the peak 5-HTinduced Ca 2 þ release from platelets of individuals with Tyr452 without difference in ligand affinity or Gprotein coupling. However, the decreased peak response seen by Ozaki et al 11 translated into a higher sustained level of Ca 2 þ release over a longer time course. Thus, the total Ca 2 þ release 90 s after 5-HT stimulation was virtually identical for both alleles, consistent with the results of the present study where Ca 2 þ release at this one time point was available.
Observations of altered 5-HT function in patients displaying impulsive aggression directed at self or others are among the most replicated findings in biological psychiatry. 12 Typically, indices of presynaptic 5-HT function have been reported to be decreased in these patients. For example, decreased 5-HIAA levels in cerebrospinal fluid have been found in impulsive, aggressive individuals, 2 patients with histories of suicide attempts, 40 short-term abstinent alcoholics, 41 and alcoholic impulsive offenders with either antisocial personality disorder or intermittent explosive disorder. 42 In contrast, postreceptor 5-HT function has typically been found to be increased in such individuals. Increased radioligand binding to 5-HT 2A receptors has been reported in patients with personality disorders and high assault scores, 28 and for patients with major depression and a history of medically damaging suicidal acts. 25 McBride et al 25 reported an increase in 5-HT 2A receptor binding in depressed/suicidal patients and also determined the ratio of 5-HT-amplified platelet aggregation to 5-HT 2A receptor number (an index of the mean responsivity of an individual 5-HT receptor complex). They found that although there were more 5-HT 2A receptors in suicide attempters vs nonattempters or normal controls, these receptors were less responsive to stimulation. Consistent with this, the present study found a significant inverse correlation between impulsivity (as measured by BIS scores) and 5-HT-induced Ca 2 þ release in platelets. Although the subjects used in this study with high impulsivity (as measured by BIS scores) show decreased postreceptor 5-HT function (as measured by platelet Ca 2 þ responses), there was no correlation between measures of impulsivity in this population and net 5-HT function (as measured by fenfluraminestimulated prolactin release). In contrast to the results of the present study, fenfluramine-stimulated prolactin release in impulsive, aggressive individuals has been reported to be reduced. This may be due to the fact that the impulsive, aggressive subjects in previous studies were patients with personality disorders, whereas not all of the subjects in the present study were diagnosed with personality disorders. One previous study has reported an inverse correlation between fenfluramine-induced prolactin secretion and impulsive aggression in a nonpatient sample. 22 The subjects in the present study were not particularly aggressive by history as shown by their relatively low BGA scores ( Table 1) , suggesting that impulsivity specifically may involve postsynaptic 5-HT function specifically, and the addition of personality disorders and high aggression may involve more of the 5-HT system.
5-HT 2A genotypes and platelet Ca
In summary, the present study has shown that subjects who show increased measures of impulsivity (as measured by BIS scores) exhibited decreased postreceptor 5-HT function (as measured by 5-HTinduced Ca 2 þ release from platelets), while their net 5-HT function (as measured by fenfluramine-induced prolactin release) was not significantly affected. The study is limited by small sample size and the possible confound of substance abuse history in a portion of subjects. Definitive association of candidate alleles to these intermediate phenotypes will require larger samples of individuals with the relevant genotypes, for example, 5-HT 2A Tyr452/Tyr452. Additional studies of the 5-HT2A Tyr452 and His452 alleles in cells expressing only these alleles may further clarify their functional significance.
